Real-world evidence of the use of glucocorticoids for severe COVID-19

INTRODUCTION: Currently, only glucocorticoids have proved to impact adverse outcomes in COVID-19. However, their risk/benefit balance remains inconclusive and populations’ characteristics should be considered. OBJECTIVE: The objective was to evaluate the real-life use of glucocorticoids in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Albarrán-Sánchez, Alejandra, Ramírez-Rentería, Claudia, Mercado, Moisés, Sánchez-García, Miriam, de Jesús Barrientos-Flores, Corazón, Ferreira-Hermosillo, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777321/
https://www.ncbi.nlm.nih.gov/pubmed/35070258
http://dx.doi.org/10.1177/20420188211072704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777321/
https://www.ncbi.nlm.nih.gov/pubmed/35070258
http://dx.doi.org/10.1177/20420188211072704

Ejemplares similares